Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Zoetis Inc

ZTS ✓ COMPLIANT ☆ Track — members

NYSE · Healthcare · Pharmaceuticals ·

USA Large Cap Analyst: BUY

Last Close

$73.79

▼ -2.70%

Market Cap $30.49B · Vol 1.37M

Key Metrics

P/E Ratio

12.14

FWD: 11.36

Market Cap

$30.49B

Large Cap

Div Yield

2.80%

Quarterly dividend

EPS Growth

-2.48%

YoY

RSI (14)

43.31

Momentum

Beta

0.72

vs Market

52W High

$160.33

53.98% below

52W Low

$71.46

3.26% above

Volume

1.37M

Avg 1.81M

P/B

16.05

Price-to-book

ROE

78.71%

Return on equity

Free Float

99.83%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Zoetis Inc (ZTS) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does ZTS pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+1.56%

-0.38%

-2.24%

-41.74%

YTD

-41.35%

-51.79%

-60.99%

-63.38%

Financials & Valuation

TTM · Annual

Total Revenue	$9.47B
Net Income	$2.67B
Revenue Growth (YoY)	-0.24%
Gross Margin	70.57%
Operating Margin	38.26%
Net Profit Margin	28.23%
ROE	78.71%
ROA · ROIC	22.62% · 24.02%

P/E Ratio	12.14
Forward P/E (FY1)	11.36
PEG Ratio	2.05
P/S	5.90
P/B	16.05
P/FCF	24.46
EPS Growth	-2.48%
Outstanding Shares	413.22M

Technical Indicators

50-Day SMA	$76.43
200-Day SMA	$106.96
RSI (14)	43.31
Beta	0.72
52-Week High	$160.33
52-Week Low	$71.46

Volume Today	1.37M
Avg Daily Volume (30D)	1.81M
Relative Volume	0.76x
Volatility (10D)	47.16
Volatility (30D)	32.75
Free Float	99.83%

Analyst Consensus

BUY

Current Price $73.79

Mean Target $100.08

52W Low$71.46 52W High$160.33

Current

Target

$71.46 $160.33

Current Analyst target

+35.63% upside potential · 21 analysts

Identifiers

ExchangeNYSE

FIGIBBG0039320P7

ISINUS98978V1035

CountryUnited States of America

Sub-IndustryVeterinary Drugs

Earnings DateNov 2, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

ELAN Elanco Animal Health Inc +5.15% 600299.SS Bluestar Adisseo Co -0.48% VIRP.PA Virbac SA +0.30% 600201.SS Jinyu Bio-Technology Co Ltd -0.81% VIMIAN.ST Vimian Group AB -0.28%

Company Profile

Zoetis Inc. is a global animal health company. The Company is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health. The Company operates through two segments: the United States (U.S.) and International. Within each of these operating segments, it offers a diversified product portfolio, including vaccines, anti-infectives, parasiticides, dermatology, pain and sedation, other pharmaceutical, and animal health diagnostics, for both companion animal and livestock customers. It directly markets its products in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America. The Company is engaged in commercializing products across eight species: dogs, cats and horses (collectively, companion animals) and cattle, poultry, swine, fish and sheep (collectively, livestock).